Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
The Journal of the Acoustical Society of America|November 2, 2015
Room acoustical parameters of two electronically connected roomsHassan El-Banna Zidan, U Peter Svensson, Johan L NielsenBlood|October 24, 2002
Relationship between hepatocellular injury and transfusional iron overload prior to and during iron chelation with desferrioxamine: a study in adult patients with acquired anemiasPeter D Jensen, Finn T Jensen, Thorkil Christensen, et al.British Journal of Haematology|January 25, 2003
Comparison of five biochemical markers of bone resorption in multiple myeloma: elevated pre-treatment levels of S-ICTP and U-Ntx are predictive for early progression of the bone disease during standard chemotherapyNiels Abildgaard, Kim Brixen, Jens E Kristensen, et al.Blood|February 11, 2003
Evaluation of myocardial iron by magnetic resonance imaging during iron chelation therapy with deferrioxamine: indication of close relation between myocardial iron content and chelatable iron poolPeter D Jensen, Finn T Jensen, Thorkil Christensen, et al.Leukemia & Lymphoma|August 25, 2009
Expression level, tissue distribution pattern, and prognostic impact of vascular endothelial growth factors VEGF and VEGF-C and their receptors Flt-1, KDR, and Flt-4 in different subtypes of non-Hodgkin lymphomasJudit M Jørgensen, Flemming B Sørensen, Knud Bendix, et al.The New England Journal of Medicine|March 15, 2003
Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemiaStephen G O'Brien, François Guilhot, Richard A Larson, et al.Acta Haematologica|May 5, 2005
Intensive treatment and stem cell transplantation in chronic myelogenous leukemia: long-term follow-upBengt Simonsson, Gunnar Oberg, Mats Bjoreman, et al.The New England Journal of Medicine|December 8, 2006
Five-year follow-up of patients receiving imatinib for chronic myeloid leukemiaBrian J Druker, François Guilhot, Stephen G O'Brien, et al.Pageof 1